lateral flow
The UK-based firm plans to finish development in the coming year of multiplex lateral flow assays for detection of multiple diseases or management of single diseases.
Senzo Closes $1.8M Financing Round to Develop its Lateral Flow Assays
The firm said it plans to use the proceeds to support the development, regulatory approval, and commercialization of its Amplified Lateral Flow tests.
Investors Acquire Diagnostics Software Firm Novarum DX from BBI Solutions
Novarum, which specializes in reading lateral flow assay results, plans to expand the range and types of diagnostic tests the company supports.
FDA Grants Emergency Use Authorization for Immunostics Home-Use COVID-19 Antigen Test
The lateral flow immunoassay is designed for qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in adults and children using nasal swab samples.
The assay detects HPV 16 and HPV 18 DNA within 45 minutes and is intended to be used in low-resource settings.